QRX Appendix 4C - Quarter Ended 31 March 2018 20/04/18 PRICE SENSITIVE download Created with Sketch. 142.86KB Share QRX Half Yearly Report and Accounts - 31 December 2017 26/02/18 PRICE SENSITIVE download Created with Sketch. 3.15MB Share QRX Suspension from Official Quotation 22/05/15 PRICE SENSITIVE download Created with Sketch. 25.05KB Share QRX Appendix 4C - Quarter Ended 31 March 2015 22/04/15 PRICE SENSITIVE download Created with Sketch. 355.74KB Share QRX Response to ASX Price Query 02/04/15 PRICE SENSITIVE download Created with Sketch. 340.21KB Share QRX Half Yearly Report and Accounts - 31 December 2014 25/02/15 PRICE SENSITIVE download Created with Sketch. 669.31KB Share QRX Appendix 4C - Quarter Ended 31 December 2014 27/01/15 PRICE SENSITIVE download Created with Sketch. 355.2KB Share QRX Appendix 4C - Quarter Ended 30 September 2014 24/10/14 PRICE SENSITIVE download Created with Sketch. 196.81KB Share QRX Preliminary Final Report - 30 June 2014 27/08/14 PRICE SENSITIVE download Created with Sketch. 1.62MB Share QRX QRxPharma Halts Moxduo Development 14/08/14 PRICE SENSITIVE download Created with Sketch. 275.61KB Share QRX Appendix 4C - Quarter Ended 30 June 2014 17/07/14 PRICE SENSITIVE download Created with Sketch. 628.88KB Share QRX Complete Response Letter from FDA regarding Moxduo NDA 26/05/14 PRICE SENSITIVE download Created with Sketch. 420.03KB Share QRX Dr. Edward Rudnic Appointed CEO of QRxPharma 02/05/14 PRICE SENSITIVE download Created with Sketch. 524.24KB Share QRX Appendix 4C - Quarter Ended 31 March 2014 29/04/14 PRICE SENSITIVE download Created with Sketch. 551.9KB Share QRX QRxPharma Issues Statement On Moxduo Advisory Committee 23/04/14 PRICE SENSITIVE download Created with Sketch. 233.1KB Share QRX Trading Halt 17/04/14 PRICE SENSITIVE download Created with Sketch. 1.16MB Share QRX Half Yearly Report and Accounts - 31 December 2013 25/02/14 PRICE SENSITIVE download Created with Sketch. 653.46KB Share QRX Appendix 4C - Quarter Ended 31 December 2013 29/01/14 PRICE SENSITIVE download Created with Sketch. 552.74KB Share QRX $4.1 Million SPP Completes A$11.6 Million Capital Raising 13/12/13 PRICE SENSITIVE download Created with Sketch. 328.79KB Share QRX MOXDUO License with TEVA for Commercialisation in Israel 27/11/13 PRICE SENSITIVE download Created with Sketch. 417.03KB Share QRX QRxPharma Refiles MOXDUO New Drug Application with the FDA 26/11/13 PRICE SENSITIVE download Created with Sketch. 326.1KB Share QRX Successful Completion of A$7.5 Million Placement 13/11/13 PRICE SENSITIVE download Created with Sketch. 329.1KB Share QRX Trading Halt 11/11/13 PRICE SENSITIVE download Created with Sketch. 267.9KB Share QRX Appendix 4C - Quarter Ended 30 September 2013 28/10/13 PRICE SENSITIVE download Created with Sketch. 600.26KB Share QRX QRxPharma Extends MOXDUO License with Aspen 15/10/13 PRICE SENSITIVE download Created with Sketch. 324.79KB Share QRX QRxPharma reports Positive Meeting with the FDA on MOXDUO 09/10/13 PRICE SENSITIVE download Created with Sketch. 325.34KB Share QRX QRxPharma Announces MOXDUO License with Aspen 11/09/13 PRICE SENSITIVE download Created with Sketch. 327.1KB Share QRX Preliminary Final Report - 30 June 2013 29/08/13 PRICE SENSITIVE download Created with Sketch. 1.43MB Share QRX Complete Response Letter from FDA regarding MOXDUO NDA 28/08/13 PRICE SENSITIVE download Created with Sketch. 423.77KB Share QRX Trading Halt 26/08/13 PRICE SENSITIVE download Created with Sketch. 128.71KB Share QRX Appendix 4C - Quarter Ended 30 June 2013 26/07/13 PRICE SENSITIVE download Created with Sketch. 603.57KB Share QRX QRxPharma Announces Collaboration with Aesica 22/07/13 PRICE SENSITIVE download Created with Sketch. 341.76KB Share QRX QRxPharma Updates MOXDUO NDA Review 26/06/13 PRICE SENSITIVE download Created with Sketch. 333.63KB Share QRX Trading Halt 26/06/13 PRICE SENSITIVE download Created with Sketch. 183.41KB Share QRX QRxPharma Granted US Patent on Hybrid Opioids 12/06/13 PRICE SENSITIVE download Created with Sketch. 324.87KB Share QRX FDA sets 17 July 2013 for MOXDUO Advisory Committee Meeting 17/05/13 PRICE SENSITIVE download Created with Sketch. 327.64KB Share QRX Appendix 4C - Quarter Ended 31 March 2013 29/04/13 PRICE SENSITIVE download Created with Sketch. 597.82KB Share QRX QRxPharma Resubmits MOXDUO New Drug Application to the FDA 28/02/13 PRICE SENSITIVE download Created with Sketch. 327.05KB Share QRX Half Yearly Report and Accounts - 31 December 2012 18/02/13 PRICE SENSITIVE download Created with Sketch. 672.41KB Share QRX Appendix 4C - Quarter Ended 31 December 2012 24/01/13 PRICE SENSITIVE download Created with Sketch. 602.09KB Share QRX Path Forward For Resubmission of MOXDUO NDA 16/01/13 PRICE SENSITIVE download Created with Sketch. 330.73KB Share QRX Appendix 4C - Quarter Ended 30 September 2012 26/10/12 PRICE SENSITIVE download Created with Sketch. 600.53KB Share QRX Strategic Collaboration with Paladin Labs 10/10/12 PRICE SENSITIVE download Created with Sketch. 382.21KB Share QRX Preliminary Final Report - 30 June 2012 30/08/12 PRICE SENSITIVE download Created with Sketch. 1002.3KB Share QRX Productive Meeting With FDA Regarding MOXDUO NDA 20/08/12 PRICE SENSITIVE download Created with Sketch. 381.12KB Share QRX Appendix 4C - Quarter Ended 30 June 2012 24/07/12 PRICE SENSITIVE download Created with Sketch. 651.35KB Share QRX Complete Response Letter from FDA regarding MOXDUO NDA 27/06/12 PRICE SENSITIVE download Created with Sketch. 380.04KB Share QRX Trading Halt 25/06/12 PRICE SENSITIVE download Created with Sketch. 280.29KB Share QRX QRxPharma Granted Additional US Patent on MoxDuo 23/05/12 PRICE SENSITIVE download Created with Sketch. 377.68KB Share QRX Appendix 4C - Quarter Ended 31 March 2012 16/04/12 PRICE SENSITIVE download Created with Sketch. 660.02KB Share QRX Successful Completion of Phase 1 Studies for MoxDuo CR 11/04/12 PRICE SENSITIVE download Created with Sketch. 384.25KB Share QRX QRxPharma Signs License and Option Agreement with Actavis 19/03/12 PRICE SENSITIVE download Created with Sketch. 385.2KB Share QRX Half Yearly Report and Accounts - 31 December 2011 24/02/12 PRICE SENSITIVE download Created with Sketch. 2.41MB Share QRX Appendix 4C - Quarter Ended 31 December 2011 30/01/12 PRICE SENSITIVE download Created with Sketch. 655.43KB Share QRX QRxPharma Announces Strategic Partnership with Actavis 21/12/11 PRICE SENSITIVE download Created with Sketch. 392.42KB Share QRX Trading Halt 20/12/11 PRICE SENSITIVE download Created with Sketch. 25KB Share QRX PDUFA Target Date for FDA Action on MoxDuo IR NDA Granted 08/11/11 PRICE SENSITIVE download Created with Sketch. 390.39KB Share QRX Appendix 4C - Quarter Ended 30 September 2011 27/10/11 PRICE SENSITIVE download Created with Sketch. 678.96KB Share QRX QRxPharma Completes NDA Submission for MoxDuo IR 25/08/11 PRICE SENSITIVE download Created with Sketch. 392.49KB Share QRX Preliminary Final Report - 30 June 2011 18/08/11 PRICE SENSITIVE download Created with Sketch. 258.27KB Share QRX Appendix 4C - Quarter Ended 30 June 2011 28/07/11 PRICE SENSITIVE download Created with Sketch. 647.12KB Share QRX QRxPharma Announces A$35 Million Capital Raising 22/07/11 PRICE SENSITIVE download Created with Sketch. 401.66KB Share QRX Trading Halt 20/07/11 PRICE SENSITIVE download Created with Sketch. 86.27KB Share QRX QRxPharma Announces NDA Filing for MoxDuo IR 18/07/11 PRICE SENSITIVE download Created with Sketch. 393.62KB Share QRX Additional Data on MoxDuo IR Comparative Safety Study 29/06/11 PRICE SENSITIVE download Created with Sketch. 766.88KB Share QRX Successful Completion MoxDuo IR Comparative Safety Study 14/06/11 PRICE SENSITIVE download Created with Sketch. 394.86KB Share QRX Appendix 4C - Quarterly Report 31 March 2011 28/04/11 PRICE SENSITIVE download Created with Sketch. 770.77KB Share QRX Enrolment of MoxDuo IR Comparative Safety Study Completed 27/04/11 PRICE SENSITIVE download Created with Sketch. 391.18KB Share QRX USPTO Issues QRxPharma a New Patent for MoxDuo IR 14/04/11 PRICE SENSITIVE download Created with Sketch. 389.83KB Share QRX QRxPharma on Track to File New Drug Application Mid-Year 28/03/11 PRICE SENSITIVE download Created with Sketch. 480.8KB Share QRX Half Yearly Report and Accounts -31 December 2010 21/02/11 PRICE SENSITIVE download Created with Sketch. 1.26MB Share QRX Successful Completion Third Pivotal MoxDuo IR Phase 3 21/02/11 PRICE SENSITIVE download Created with Sketch. 393.4KB Share QRX Appendix 4C - 31 December 2010 27/01/11 PRICE SENSITIVE download Created with Sketch. 660.17KB Share QRX Initiation of Phase 3 Comparative Safety Study of MoxDuo IR 24/01/11 PRICE SENSITIVE download Created with Sketch. 394.6KB Share QRX Enrolment of Pivotal MoxDuo IR Phase 3 Study Completed 06/12/10 PRICE SENSITIVE download Created with Sketch. 403.72KB Share QRX Additional U.S.Therapeutic Discovery Project Grant Awarded 08/11/10 PRICE SENSITIVE download Created with Sketch. 467.42KB Share QRX MoxDuo Awarded U.S. Therapeutic Discovery Project Grants 04/11/10 PRICE SENSITIVE download Created with Sketch. 455.36KB Share QRX Appendix 4C -30 September 2010 27/10/10 PRICE SENSITIVE download Created with Sketch. 661.75KB Share QRX A$14 Million Placement together with a Share Purchase Plan 01/10/10 PRICE SENSITIVE download Created with Sketch. 413.16KB Share QRX Trading Halt 29/09/10 PRICE SENSITIVE download Created with Sketch. 93.42KB Share QRX Interim Analysis of Final Pivotal Phase 3 Study MoxDuoIR 01/09/10 PRICE SENSITIVE download Created with Sketch. 402.04KB Share QRX Preliminary Final Report - 30 June 2010 26/08/10 PRICE SENSITIVE download Created with Sketch. 668.44KB Share QRX Positive Phase 2 Proof of Concept Data for MoxDuoIV 09/08/10 PRICE SENSITIVE download Created with Sketch. 502.51KB Share QRX Positive Scientific Advice Meetings in Europe MoxDou IR 26/07/10 PRICE SENSITIVE download Created with Sketch. 408.49KB Share QRX Appendix 4C - 30 June 2010 26/07/10 PRICE SENSITIVE download Created with Sketch. 516.95KB Share QRX Phase 1 PK Study for MoxDuoCR Tablet Formula Successful 10/05/10 PRICE SENSITIVE download Created with Sketch. 289.6KB Share QRX Response to ASX Query - Appendix 4C 06/05/10 PRICE SENSITIVE download Created with Sketch. 102.75KB Share QRX Phase 3 Combination Rule Study for MoxDuo IR Additional Data 04/05/10 PRICE SENSITIVE download Created with Sketch. 292.54KB Share QRX Appendix 4C - Quarterly Report 31 March 2010 27/04/10 PRICE SENSITIVE download Created with Sketch. 379.58KB Share QRX Phase 3 Combination Rule Study for MoxDuoIR Successful 14/04/10 PRICE SENSITIVE download Created with Sketch. 292.13KB Share QRX Phase 1 Trial of Controlled-Release Dual-Opioid Initiated 30/03/10 PRICE SENSITIVE download Created with Sketch. 292.31KB Share QRX Strategic Alliance for Development of MoxDuo IV 23/02/10 PRICE SENSITIVE download Created with Sketch. 312.96KB Share QRX Half Yearly Report and Accounts - 31 December 2009 17/02/10 PRICE SENSITIVE download Created with Sketch. 683.52KB Share QRX QRxPharma Initiates Second Pivotal Phase 3 Study MoxDuoIR 10/02/10 PRICE SENSITIVE download Created with Sketch. 293.29KB Share QRX Appendix 4C - Quarterly Report 31 December 2009 27/01/10 PRICE SENSITIVE download Created with Sketch. 497.47KB Share QRX QRxPharma Initiates Pivotal Phase 3 Study of MoxDuoIR 30/11/09 PRICE SENSITIVE download Created with Sketch. 173.98KB Share QRX Reinstatement to Official Quotation 16/11/09 PRICE SENSITIVE download Created with Sketch. 22.19KB Share QRX A$21.6 Million Fully Underwritten Placement and Rights Issue 16/11/09 PRICE SENSITIVE download Created with Sketch. 277.08KB Share QRX Suspension from Official Quotation 13/11/09 PRICE SENSITIVE download Created with Sketch. 93.37KB Share QRX QRxPharma Investor Update and Capital Raising 11/11/09 PRICE SENSITIVE download Created with Sketch. 926.69KB Share
